Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.
Condition: Insulin Resistance Interventions: Drug: Metformin group; Drug: Rosiglitazone group; Drug: Placebo oral tablet Sponsors: J JESUS VENEGAS, MD; Instituto Mexicano del Seguro Social; National Council of Science and Technology, Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Conditions: Melanoma; Renal Cell Carcinoma; NSCLC; Hepatocellular Carcinoma; Urothelial Cancer; Gastric Adenocarcinoma; HNSCC; Esophageal Adenocarcinoma; Microsatellite Instability-High Solid Malignant Tumor Interventions: Drug: Nivolumab or Pembrolizumab (dependent upon approved indication); Drug: Metformin; Drug: Rosiglitazone Sponsor: Dan Zandberg Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2019 Category: Research Source Type: clinical trials
